G39213VZ
| Organisms | Evidence |
|---|---|
| Mus musculus (house mouse) | |
| Bos taurus (domestic cattle) | |
| Gallus gallus (chicken) | |
| Rattus norvegicus (Norway rat) | |
| Homo sapiens (human) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| FUT11 | GDP-Fuc |
|
R |
|
R | |
| FUT10 | GDP-Fuc |
|
R |
|
R | |
| MGAT4A | UDP-GlcNAc |
|
PA |
|
PA | |
| MGAT3 | UDP-GlcNAc |
|
Asn-X |
|
Asn-X | |
| MGAT4B | UDP-GlcNAc |
|
PA |
|
PA |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| FUT11 | GDP-Fuc |
|
R |
|
R | |
| FUT8 | GDP-Fuc |
|
Free |
|
Free | |
| FUT10 | GDP-Fuc |
|
R |
|
R | |
| MGAT4A | UDP-GlcNAc |
|
PA |
|
PA | |
| MGAT5 | UDP-GlcNAc |
|
[beta]1-Asn |
|
[beta]1-Asn |
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| P13987 | CD59 glycoprotein | ||
| P29965 | CD40 ligand | ||
| P31994 | Low affinity immunoglobulin gamma Fc region receptor II-b | ||
| Q7SIB2 | Collagen alpha-1(IV) chain | ||
| Q7SIB3 | Collagen alpha-2(IV) chain (Fragment) | ||
| Q9BYF1 | Angiotensin-converting enzyme 2 | ||
| Q9TRC7 | Diamine oxidase [copper-containing] |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl 3b:b-dglc-HEX-1:5 4s:n-acetyl 5b:b-dman-HEX-1:5 6b:a-dman-HEX-1:5 7b:b-dglc-HEX-1:5 8s:n-acetyl 9b:a-dman-HEX-1:5 10b:b-dglc-HEX-1:5 11s:n-acetyl LIN 1:1d(2+1)2n 2:1o(4+1)3d 3:3d(2+1)4n 4:3o(4+1)5d 5:5o(3+1)6d 6:6o(2+1)7d 7:7d(2+1)8n 8:5o(6+1)9d 9:9o(2+1)10d 10:10d(2+1)11n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 34834161 | Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity | Cruz E | 2021 Oct 20 |
|
| 34207636 | What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease? | Gaunitz S | 2021 Jun 9 |
|
| 34106099 | N-Glycosylation in isolated rat nerve terminals | Matthies I | 2021 Aug 1 |
|
| 33139572 | Spatial and temporal diversity of glycome expression in mammalian brain | Lee Jua | 2020-11-17 |
|
| 31889402 | Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment | Schedin-Weiss Sophia | 2020-08 |
|
| 32841605 | Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor | Zhao P | 2020 Oct 07 |
|
| 32080177 | Structural basis for substrate specificity and catalysis of α1,6-fucosyltransferase | García-García A | 2020 Feb 20 |
|
| 29671580 | Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and alpha-1B-Glycoprotein | Sun S | 2018 Apr 19 |
|
| 26595420 | Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab | Scapin G | 2015 Nov 23 |
|
| 25345863 | Fc Gamma Receptor Glycosylation Modulates the Binding of IgG Glycoforms: A Requirement for Stable Antibody Interactions | Hayes JM | 2014 Nov 11 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025